The roles of hASH1 gone in neuroendocrine differentiation of lung cancer and in the development of the lung

hASH1在肺癌神经内分泌分化及肺发育中的作用

基本信息

  • 批准号:
    15590314
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

hASH1 mRNA expression was investigated by in situ hybridization in 238 surgically resected lung carcinomas, and the correlations between hASH1 expression and general neuroendocrine marker and peptide hormone expression as well as clinical outcome were analyzed. hASH1 expression was restricted to tumors with neuroendocrine phenotypes. However, not all neuroendocrine tumors expressed hASH1 and hASH1 expression correlated closely with chromogranin A, gastrin-releasing peptide and calcitonin (P<0.0001, r=0.852), but was not related to neural cell adhesion expression (P=0.8892), suggesting that hASH1 expression, at least in lung cancer, is associated with endocrine phenotype expression other than 'neuroendocrine differentiation' in a broad sense. That hASH1 was virtually absent in almost fully differentiated typical carcinoids (TC), but was expressed in most, if not all, less differentiated atypical carcinoids (ATC) as well as large-cell neuroendocrine carcinoma (LCNEC) and small cell lung … More carcinoma (SCLC), suggests that hASH1 expression in lung cancer imitates its early and transient expression in fetal development, and that hASH1 is instrumental in the establishment, but not in the maintenance, of a cellular endocrine phenotype. Finally, hASH1 expression correlated with a significantly shortened survival in SCLC patients (P=0.041).Dysregulated cyclin B1 expression and disruption of the Rb/p16/cyclin D1 pathway (Rb pathway) were also studied, and the results were correlated with tumor proliferation activity and clinical outcome. Both cyclin B1-associated G2/M arrest and Rb-mediated G1 arrest are consistently compromised in high-grade LCNEC and SCLC, but are generally intact or occasionally altered in TC/ATC ; and the mechanisms involved in Rb pathway aberration among the tumor categories are different. Cyclin B1 expression closely correlated with the Ki-67 labeling index in each tumor category (P<0.0001, r=0.742), suggesting a key role for cyclin B1 in regulating cell proliferation. Neither cyclins B1 and D1, Rb, p16, nor Ki-67 correlated with patient survival in individual tumor categories. Less
应用原位杂交技术检测238例手术切除的肺癌组织中hASH1 mRNA的表达,并分析其与神经内分泌标志物、肽类激素表达及临床预后的关系。hASH1表达仅限于具有神经内分泌表型的肿瘤。然而,并非所有神经内分泌肿瘤都表达hASH1,hASH1的表达与嗜铬粒蛋白A、胃泌素释放肽和降钙素密切相关(P <0.0001,r = 0.852),但与神经细胞粘附表达无关(P = 0.8892),表明hASH1表达,至少在肺癌中,与广义上的"神经内分泌分化"以外的内分泌表型表达相关。hASH1在几乎完全分化的典型类癌(TC)中几乎不存在,但在大多数(如果不是全部的话)低分化的非典型类癌(ATC)以及大细胞神经内分泌癌(LCNEC)和小细胞肺癌(NSCLC)中表达。 ...更多信息 小细胞肺癌(SCLC)的研究表明,hASH1在肺癌中的表达模仿其在胎儿发育中的早期和瞬时表达,并且hASH1有助于细胞内分泌表型的建立,但不是维持细胞内分泌表型。最后,hASH1表达与SCLC患者生存期显著缩短相关(P = 0.041)。我们还研究了细胞周期蛋白B1表达失调和Rb/p16/细胞周期蛋白D1通路(Rb通路)的破坏,并将结果与肿瘤增殖活性和临床结局相关。细胞周期蛋白B1相关的G2/M期阻滞和Rb介导的G1期阻滞在高级别LCNEC和SCLC中始终受到损害,但在TC/ATC中通常是完整的或偶尔改变; Rb通路畸变的机制在肿瘤类别中是不同的。Cyclin B1表达与Ki-67标记指数在各肿瘤类型中密切相关(P <0.0001,r = 0.742),提示cyclin B1在调节细胞增殖中起关键作用。无论是细胞周期蛋白B1和D1,Rb,p16,也没有Ki-67与患者的生存在个别肿瘤类别。少

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pathology and Genetics of Tuomurs of the Lung, Pleura, Thymus and Heart (IARC/World Health Organization Classification of Tumours)
肺、胸膜、胸腺和心脏肿瘤的病理学和遗传学(IARC/世界卫生组织肿瘤分类)
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Dobashi;Y. et al.;Jiang SX et al. (分担者)
  • 通讯作者:
    Jiang SX et al. (分担者)
Hirokuni Kakinuma et al.: "Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas"Cancer. 99・4. 247-254 (2003)
Hirokuni Kakinuma 等:“大肺细胞神经内分泌癌的支气管刷细胞学诊断结果”癌症 247-254(2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
肺の大細胞性神経内分泌癌(LCNEC)の診断
肺大细胞神经内分泌癌(LCNEC)的诊断
Diversity in expression and prognostic significance of G1/S cyclins in human pulmonary lung carcinomas
G1/S细胞周期蛋白在人肺癌中的表达多样性及其预后意义
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Igarashi T;Shi-Xu Jiang et al.;Kakinuma H et al.;Dobashi Y et al.
  • 通讯作者:
    Dobashi Y et al.
Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas
肺大细胞神经内分泌癌支气管刷细胞学诊断结果
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Igarashi T;Shi-Xu Jiang et al.;Kakinuma H et al.
  • 通讯作者:
    Kakinuma H et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JIANG Shi-xu其他文献

JIANG Shi-xu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JIANG Shi-xu', 18)}}的其他基金

A study on the mechanisms underlying resistance acquisition of lung cancer for tyrosine kinase inhibitors
肺癌酪氨酸激酶抑制剂获得耐药机制的研究
  • 批准号:
    21590384
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinicopathological features of gastric neuroendocrine carcinomas and the roles of hASH1/HES1 in neuroendocrine differentiation of gastric cancers
胃神经内分泌癌的临床病理特征及hASH1/HES1在胃癌神经内分泌分化中的作用
  • 批准号:
    17590316
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Metabolome analysis for pancreatic neuroendocrine tumor
胰腺神经内分泌肿瘤的代谢组分析
  • 批准号:
    21K07193
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor
非功能性胰腺神经内分泌肿瘤染色质重塑生物标志物的预后意义和机制确定
  • 批准号:
    10451759
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor
非功能性胰腺神经内分泌肿瘤染色质重塑生物标志物的预后意义和机制确定
  • 批准号:
    10279379
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor
非功能性胰腺神经内分泌肿瘤染色质重塑生物标志物的预后意义和机制确定
  • 批准号:
    10664894
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanism of neuroendocrine tumor suppression by the tumor suppressor gene PHLDA3
抑癌基因PHLDA3抑制神经内分泌肿瘤的机制
  • 批准号:
    20H03523
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Somatostatin receptor 2 (SSTR2) antibody-drug conjugate for pancreatic neuroendocrine tumor (PanNET) therapy
用于胰腺神经内分泌肿瘤 (PanNET) 治疗的生长抑素受体 2 (SSTR2) 抗体-药物偶联物
  • 批准号:
    9895383
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Identifying Actionable Signatures of Duodenopancreatic Neuroendocrine Tumor Progression in MEN1
识别 MEN1 十二指肠胰腺神经内分泌肿瘤进展的可操作特征
  • 批准号:
    10041298
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of novel therapeutics for pancreatic neuroendocrine tumor targeting microRNA
开发靶向 microRNA 的胰腺神经内分泌肿瘤新疗法
  • 批准号:
    19K07470
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of liver metastasis-related mechanisms in CNPY2 for gastroenteropancreatic neuroendocrine tumor
阐明CNPY2治疗胃肠胰神经内分泌肿瘤肝转移的相关机制
  • 批准号:
    19K09187
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of PDX model in pancreatic neuroendocrine tumor
胰腺神经内分泌肿瘤PDX模型的建立
  • 批准号:
    18K16345
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了